These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 16336002)

  • 1. Antimycotic drug discovery in the age of genomics.
    Cleary JD; Walker LA; Hawke RL
    Am J Pharmacogenomics; 2005; 5(6):365-86. PubMed ID: 16336002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomics, molecular targets and the discovery of antifungal drugs.
    Odds FC
    Rev Iberoam Micol; 2005 Dec; 22(4):229-37. PubMed ID: 16499416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Organic Antifungal Drugs and Targets of Their Action.
    Maksimov AY; Balandina SY; Topanov PA; Mashevskaya IV; Chaudhary S
    Curr Top Med Chem; 2021; 21(8):705-736. PubMed ID: 33423647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress in functional genomics approaches to antifungal drug target discovery.
    De Backer MD; Van Dijck P
    Trends Microbiol; 2003 Oct; 11(10):470-8. PubMed ID: 14557030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fungal pathogens research: novel and improved molecular approaches for the discovery of antifungal drug targets.
    Tournu H; Serneels J; Van Dijck P
    Curr Drug Targets; 2005 Dec; 6(8):909-22. PubMed ID: 16375674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current and future approaches to antimycotic treatment in the era of resistant fungi and immunocompromised hosts.
    Bastert J; Schaller M; Korting HC; Evans EG
    Int J Antimicrob Agents; 2001 Feb; 17(2):81-91. PubMed ID: 11165110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting efflux pumps to overcome antifungal drug resistance.
    Holmes AR; Cardno TS; Strouse JJ; Ivnitski-Steele I; Keniya MV; Lackovic K; Monk BC; Sklar LA; Cannon RD
    Future Med Chem; 2016 Aug; 8(12):1485-501. PubMed ID: 27463566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies in the discovery of novel antifungal scaffolds.
    Liu N; Wang C; Su H; Zhang W; Sheng C
    Future Med Chem; 2016 Aug; 8(12):1435-54. PubMed ID: 27463376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outwitting multidrug resistance to antifungals.
    Monk BC; Goffeau A
    Science; 2008 Jul; 321(5887):367-9. PubMed ID: 18635793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hybrid Molecules Development: A Versatile Landscape for the Control of Antifungal Drug Resistance: A Review.
    Anusionwu CG; Aderibigbe BA; Mbianda XY
    Mini Rev Med Chem; 2019; 19(6):450-464. PubMed ID: 30526457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo evaluation of antifungal agents.
    Espinel-Ingroff A; Shadomy S
    Eur J Clin Microbiol Infect Dis; 1989 Apr; 8(4):352-61. PubMed ID: 2497014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The antifungal pipeline: the need is established. Are there new compounds?
    Li D; She X; Calderone R
    FEMS Yeast Res; 2020 Jun; 20(4):. PubMed ID: 32353872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recent progress in the study of fungal virulence factors and identification of new targets of anti-fungal drug using proteomic and transcriptomic analysis].
    Toyotome T; Watanabe A; Kamei K
    Nihon Rinsho; 2008 Dec; 66(12):2255-60. PubMed ID: 19069088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential targets for the development of new antifungal drugs.
    Su H; Han L; Huang X
    J Antibiot (Tokyo); 2018 Nov; 71(12):978-991. PubMed ID: 30242283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Present status of antimycotics.
    Kerridge D
    Microbiol Sci; 1985; 2(3):78, 83-6. PubMed ID: 3939997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic and genetic approaches for the identification of antifungal drug targets.
    Agarwal AK; Xu T; Jacob MR; Feng Q; Li XC; Walker LA; Clark AM
    Infect Disord Drug Targets; 2008 Mar; 8(1):2-15. PubMed ID: 18473903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and pharmacodynamics in the development of antifungal compounds.
    Andes D
    Curr Opin Investig Drugs; 2003 Aug; 4(8):991-8. PubMed ID: 14508883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Harnessing the power of the genome in the search for new antibiotics.
    Rosamond J; Allsop A
    Science; 2000 Mar; 287(5460):1973-6. PubMed ID: 10720317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New advances in antifungal agents].
    Matsumoto S; Hatano K; Maki K
    Nihon Yakurigaku Zasshi; 2007 Jul; 130(1):45-51. PubMed ID: 17634680
    [No Abstract]   [Full Text] [Related]  

  • 20. [Current status of studies on sensitivity to antifungal agents].
    Martín Mazuelos E
    Enferm Infecc Microbiol Clin; 1992; 10(6):366-71. PubMed ID: 1391021
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.